ONCGNOSTICS GMBH
oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable in vitro diagnostic (=IVD) tests for screening, therapeutic decisions and follow-up care in cancer diagnostics. The diagnostic tests developed by oncgnostics are based on DNA regions specifically methylated in precancerous and carcinoma cells. These marker regions are detected using well-established PCR-based technologies, which can be performed in routine molecular diagnostics laboratories with standard equipment. oncgnostics has identified novel markers for detecting cervical precancerous lesions and carcinomas.
ONCGNOSTICS GMBH
Industry:
Biotechnology Health Diagnostics Medical Robotics
Founded:
2012-02-01
Address:
Jena, Thuringen, Germany
Country:
Germany
Website Url:
http://www.oncgnostics.com
Total Employee:
1+
Status:
Active
Contact:
49 3641 933544
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Diagnolita
Diagnolita specializes in providing modern diagnostic services and prostate cancer diagnostics.
Current Employees Featured
Founder
Investors List
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - oncgnostics GmbH
Sparkasse Jena
Sparkasse Jena investment in Series A - oncgnostics GmbH
bm-t beteiligungsmanagement thuringen
bm-t beteiligungsmanagement thuringen investment in Series A - oncgnostics GmbH
ITAI GmbH
ITAI GmbH investment in Series A - oncgnostics GmbH
STIFT Thueringen
STIFT Thueringen investment in Series A - oncgnostics GmbH
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - oncgnostics GmbH
STIFT Thueringen
STIFT Thueringen investment in Seed Round - oncgnostics GmbH
Official Site Inspections
http://www.oncgnostics.com Semrush global rank: 3.9 M Semrush visits lastest month: 3.26 K
- Host name: dd28818.kasserver.com
- IP address: 85.13.147.67
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "oncgnostics GmbH"
Home - oncgnostics GmbH
Dec 18, 2024 oncgnostics GmbH – Molecular Biotechnology from Jena. Jena provides us, oncgnostics GmbH, with the advantages of the university and high-tech city that allows us to …See details»
Willkommen bei der oncgnostics GmbH
Oncgnostics GmbH – Molekulare Biotechnologie aus Jena. Im Herzen von Jena gelegen nutzen wir, die oncgnostics GmbH, die Vorzüge der Universitätsstadt, um als junges Forschungsteam …See details»
About us - oncgnostics GmbH
The oncgnostics GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on …See details»
Oncgnostics - Crunchbase Company Profile & Funding
The diagnostic tests developed by oncgnostics are based on DNA regions specifically methylated in precancerous and carcinoma cells. These marker regions are detected using well …See details»
oncgnostics GmbH - LinkedIn
Oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer ...See details»
oncgnostics 2025 Company Profile: Valuation, Funding & Investors ...
What industry is oncgnostics in? oncgnostics’s primary industry is Diagnostic Equipment. Is oncgnostics a private or public company? oncgnostics is a Private company. What is …See details»
oncgnostics GmbH Company Profile | Jena, Thüringen, Germany ...
Find company research, competitor information, contact details & financial data for oncgnostics GmbH of Jena, Thüringen. Get the latest business insights from Dun & Bradstreet.See details»
oncgnostics (Oncgnostics GmbH)
Legal Entity: Oncgnostics GmbH Location: Thüringen Overview Company Funding Product Team News Is this your company? Profile is not claimed et. This profile is created by the Startbase Analyst Team. If you are a team member of …See details»
oncgnostics - VentureRadar
The oncgnostics GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on …See details»
oncgnostics (Oncgnostics GmbH) - startbase.de
Nachrichten über oncgnostics. Umfassende Startup-Listen: Startups aus Jena Startups aus Thüringen Startups aus Deutschland. Die neusten Erwähnungen von oncgnostics in Podcasts & Videos: Offene Jobs bei oncgnostics: Vielleicht …See details»
Oncgnostics - Funding, Financials, Valuation & Investors
Sep 5, 2023 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead ... Series A - Oncgnostics . …See details»
Oncgnostics - 2025 Company Profile, Funding & Competitors
Mar 20, 2025 Oncgnostics. has raised a total funding of $1.42M over 5 rounds. Its first funding round was on Apr 16, 2012. List of recent funding rounds of Oncgnostics. Date of funding. …See details»
oncgnostics GmbH - Company Profile & Staff Directory - ContactOut
Oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable in vitro diagnostic (=IVD) tests for screening, therapeutic decisions and follow-up care in cancer …See details»
oncgnostics Company Profile - Office Locations, Competitors, …
Oncgnostics is a company specializing in the development of molecular assays based on epigenetic biomarkers. It offers molecular in vitro diagnostic (IVD) tests for screening, follow …See details»
Oncgnostics - Contacts, Employees, Board Members, Advisors
Oncgnostics has 5 current employee profiles, including Founding Angel, Head of Business Development and Licensing Peter Haug. Peter Haug Founding Angel, Head of Business …See details»
About oncgnostics - oncgnostics GmbH
The oncgnostics GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on …See details»
oncgnostics GmbH
Jena, 22. Juli 2024. Oncgnostics GmbH unterzeichnet einen Vertrag über die internationale Distribution der eigenen Tests mit der Seegene Germany GmbH.Dr. Alfred Hansel, …See details»
Oncgnostics GmbH Profile - medical-xprt.com
As a biotechnology company, we at oncgnostics GmbH have been working on the diagnosis of cancer on a molecular biological basis since 2012. Our cancer tests are used in early cancer …See details»
oncgnostics • startup | HTGF
Oncgnostics develops, based on proprietary epigenetic biomarkers molecular tests for reliable cancer diagnostics. With the seed financing through High-tech Gruenderfonds (HTGF) and …See details»
oncgnostics | VentureRadar
The oncgnostics GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on …See details»